Skip to main content

AI Biotech Wins $4.3M Sequencing Data Contract

NEW YORK (GenomeWeb News) – Contract research organization AI Biotech announced it has received a 30-month, $4.3 million contract to carry out a next-generation sequencing project.

The work being carried out is classified and company President and CSO Robert Harris declined to provide specifics about the project to GenomeWeb Daily News, saying only that it is broad-based and will involve the sequencing of "many individual human genomes." The goal is to develop genomic information and methods of handling and processing the data.

He said is he is not allowed to identify the US government agency that awarded AI Biotech the contract.

AI Biotech is based in Richmond, Va., and provides research services, drug development, assay development, and clinical testing services to life science organizations.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.